Next Issue
Previous Issue

Table of Contents

Pharmaceuticals, Volume 4, Issue 11 (November 2011), Pages 1400-1517

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Readerexternal link to open them.
Display options:
Select articles Export citation of selected articles as:
Select/unselect all
Displaying article 1-7

Research

Jump to: Review

p. 1423-1433
by , , , , , , ,  and
Pharmaceuticals 2011, 4(11), 1423-1433; doi:10.3390/ph4111423
Received: 14 October 2011; Accepted: 17 October 2011 / Published: 25 October 2011
Show/Hide Abstract | PDF Full-text (3202 KB) | HTML Full-text | XML Full-text
p. 1488-1502
by , , , ,  and
Pharmaceuticals 2011, 4(11), 1488-1502; doi:10.3390/ph4111488
Received: 1 September 2011; in revised form: 1 November 2011 / Accepted: 7 November 2011 / Published: 10 November 2011
Show/Hide Abstract | PDF Full-text (322 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Hsp90 Inhibitors)
p. 1503-1517
by ,  and
Pharmaceuticals 2011, 4(11), 1503-1517; doi:10.3390/ph4111503
Received: 12 October 2011; in revised form: 26 October 2011 / Accepted: 7 November 2011 / Published: 11 November 2011
Show/Hide Abstract | Cited by 1 | PDF Full-text (1086 KB) | HTML Full-text | XML Full-text | Supplementary Files
(This article belongs to the Special Issue Emerging Pain Targets and Therapy)

Review

Jump to: Research

p. 1400-1422
by  and
Pharmaceuticals 2011, 4(11), 1400-1422; doi:10.3390/ph4111400
Received: 31 August 2011; in revised form: 4 October 2011 / Accepted: 17 October 2011 / Published: 25 October 2011
Show/Hide Abstract | Cited by 8 | PDF Full-text (384 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Hsp90 Inhibitors)
p. 1434-1449
by , , ,  and
Pharmaceuticals 2011, 4(11), 1434-1449; doi:10.3390/ph4111434
Received: 22 September 2011; in revised form: 13 October 2011 / Accepted: 24 October 2011 / Published: 27 October 2011
Show/Hide Abstract | Cited by 2 | PDF Full-text (254 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Aptamer-Based Therapeutics)
p. 1450-1474
by , , ,  and
Pharmaceuticals 2011, 4(11), 1450-1474; doi:10.3390/ph4111450
Received: 8 August 2011; in revised form: 20 October 2011 / Accepted: 20 October 2011 / Published: 27 October 2011
Show/Hide Abstract | Cited by 5 | PDF Full-text (787 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Advances in Drug Design)
abstract graphic
p. 1475-1487
by
Pharmaceuticals 2011, 4(11), 1475-1487; doi:10.3390/ph4111475
Received: 13 September 2011; in revised form: 22 October 2011 / Accepted: 24 October 2011 / Published: 7 November 2011
Show/Hide Abstract | PDF Full-text (205 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Anticoagulants)
Select/unselect all
Displaying article 1-7
Select articles Export citation of selected articles as:
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert